Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin TDPPR Group New England Journal of Medicine. 346 (6), 393-403, 2002 | 25462 | 2002 |
Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 16717 | 2014 |
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis AJ Sanyal, N Chalasani, KV Kowdley, A McCullough, AM Diehl, NM Bass, ... New England Journal of Medicine 362 (18), 1675-1685, 2010 | 3756 | 2010 |
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Diabetes Prevention Program Research Group The Lancet 374 (9702), 1677-1686, 2009 | 3583 | 2009 |
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes Look AHEAD Research Group New England journal of medicine 369 (2), 145-154, 2013 | 3057 | 2013 |
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial BA Neuschwander-Tetri, R Loomba, AJ Sanyal, JE Lavine, ML Van Natta, ... The Lancet 385 (9972), 956-965, 2015 | 2438 | 2015 |
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial Look AHEAD Research Group Diabetes care 30 (6), 1374-1383, 2007 | 2001 | 2007 |
The prevalence and etiology of elevated aminotransferase levels in the United States JM Clark, FL Brancati, AM Diehl Official journal of the American College of Gastroenterology| ACG 98 (5 …, 2003 | 1835 | 2003 |
Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta‐analysis R Hernaez, M Lazo, S Bonekamp, I Kamel, FL Brancati, E Guallar, ... Hepatology 54 (3), 1082-1090, 2011 | 1608 | 2011 |
Nonalcoholic fatty liver disease JM Clark, FL Brancati, AM Diehl Gastroenterology 122 (6), 1649-1657, 2002 | 1350 | 2002 |
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial JE Lavine, JB Schwimmer, ML Van Natta, JP Molleston, KF Murray, ... Jama 305 (16), 1659-1668, 2011 | 1314 | 2011 |
The epidemiology of nonalcoholic fatty liver disease in adults JM Clark Journal of clinical gastroenterology 40, S5-S10, 2006 | 1178 | 2006 |
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits EK Speliotes, LM Yerges-Armstrong, J Wu, R Hernaez, LJ Kim, ... PLoS genetics 7 (3), e1001324, 2011 | 1103 | 2011 |
The epidemiology of nonalcoholic fatty liver disease: a global perspective M Lazo, JM Clark Seminars in liver disease 28 (04), 339-350, 2008 | 1001 | 2008 |
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994 M Lazo, R Hernaez, MS Eberhardt, S Bonekamp, I Kamel, E Guallar, ... American journal of epidemiology 178 (1), 38-45, 2013 | 971 | 2013 |
Comparative effectiveness of weight-loss interventions in clinical practice LJ Appel, JM Clark, HC Yeh, NY Wang, JW Coughlin, G Daumit, ... New England Journal of Medicine 365 (21), 1959-1968, 2011 | 907 | 2011 |
Association of an intensive lifestyle intervention with remission of type 2 diabetes EW Gregg, H Chen, LE Wagenknecht, JM Clark, LM Delahanty, J Bantle, ... Jama 308 (23), 2489-2496, 2012 | 831 | 2012 |
Serum ferritin and risk of the metabolic syndrome in US adults M Jehn, JM Clark, E Guallar Diabetes care 27 (10), 2422-2428, 2004 | 598 | 2004 |
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease BA Neuschwander‐Tetri, JM Clark, NM Bass, ML Van Natta, ... Hepatology 52 (3), 913-924, 2010 | 591 | 2010 |
Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis JM Clark, AM Diehl Jama 289 (22), 3000-3004, 2003 | 576 | 2003 |